Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL30860168 | 1.00 | — | — | |
| Iodide SCHEMBL5002237 | 0.98 | HRH1 (0.50) | — | |
| SCHEMBL215763 | 0.97 | — | — | |
| SCHEMBL7845475 | 0.97 | — | — | |
| SCHEMBL29375505 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL57551 | 0.95 | — | — | |
| Bromide SCHEMBL28406374 | 0.95 | — | — | |
| Phosphine SCHEMBL21829630 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL28692185 | 0.95 | HRH1 (0.52) | — | |
| Hydrochloric Acid SCHEMBL4139262 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099144-A1 | SELF-CROSSLINKED HYDROGEL COMBINATION WITH BOTULINUM NEUROTOXIN | MERZ PHARMA GMBH & CO. KGAA (DE) | 2026-05-15 | — | — | WO | claimed |
| CN-118718089-A | Injectable fat decellularized biological material and preparation method thereof | 上海萨特丽生物科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| EP-1144459-B2 | CROSS-LINKED HYALURONIC ACIDS AND MEDICAL USES THEREOF | SIGMAR ITALIA S P A (IT) | 2011-02-23 | — | — | EP | claimed |
| EP-1137670-B1 | CROSS-LINKING PROCESS OF CARBOXYLATED POLYSACCHARIDES | FARMILA THEA FARMACEUTICI S P (IT) | 2005-03-23 | — | — | EP | claimed |
| CN-1144818-C | Method for cross-linking carboxylated polysaccharides | ����˹�ٰ¹ɷݹ�˾ | 2004-04-07 | — | — | CN | claimed |
| CN-1325409-A | Cross-linking process for carboxylated polysaccharides | AQUISITIO S P A (IT) | 2001-12-05 | — | — | CN | claimed |
| WO-2001085801-A1 | CROSS-LINKED POLYMERS USEFUL FOR THE PHARMACEUTICAL, MEDICAL AND COSMETIC USES | AQUISITIO S.P.A. (IT) | 2001-11-15 | — | — | WO | claimed |
| WO-2026099144-A1 | SELF-CROSSLINKED HYDROGEL COMBINATION WITH BOTULINUM NEUROTOXIN | MERZ PHARMA GMBH & CO. KGAA (DE) | 2026-05-15 | — | — | WO | disclosed |
| EP-4719510-A1 | CROSS-LINKED MATERIAL COMPRISING POLYSACCHARIDE MOIETIES INTERCONNECTED BY ESTER BONDS | Merz Aesthetics GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-20260022116-A1 | IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF | SANOFI-AVENTIS RECHERCHE & DÉVELOPPEMENT (FR) | 2026-01-22 | — | — | US | disclosed |
| US-12478621-B2 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2025-11-25 | — | — | US | disclosed |
| EP-4593867-A2 | LONG-ACTING PARATHYROID HORMONE | Extend Biosciences, Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250228920-A1 | LONG-ACTING PARATHYROID HORMONE | EXTEND BIOSCIENCES, INC. (US) | 2025-07-17 | — | — | US | disclosed |
| EP-0667853-A1 | METHOD OF SYNTHESISING PHYTOSPHINGOSINE-CONTAINING CERAMIDES AND COSMETIC COMPOSITIONS COMPRISING THEM | QUEST INTERNATIONAL NEDERLAND BV (NL) | 1995-08-23 | — | — | EP | disclosed |
| WO-1994020516-A1 | NEW SULFATED LYSO-GANGLIOSIDE DERIVATIVES | FIDIA S.P.A. (IT) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994010131-A1 | METHOD OF SYNTHESISING PHYTOSPHINGOSINE-CONTAINING CERAMIDES AND COSMETIC COMPOSITIONS COMPRISING THEM | UNILEVER PLC (GB) | 1994-05-11 | — | — | WO | disclosed |
| EP-0373039-B1 | New lysoganglioside derivatives | FIDIA SPA (IT) | 1994-04-06 | — | — | EP | disclosed |
| WO-1994000473-A2 | PENTAVALENT SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING STEREOSPECIFIC ALKYLPHOSPHONATES AND ARYLPHOSPHONATES | RES CORP TECHNOLOGIES INC (US) | 1994-01-06 | — | — | WO | disclosed |
| US-5102881-A | Leukotriene biosynthesis inhibitor | MERCK FROSST CANADA, INC. (CA) | 1992-04-07 | — | — | US | disclosed |
| EP-0373039-A2 | New lysoganglioside derivatives | FIDIA S.p.A. (IT) | 1990-06-13 | — | — | EP | disclosed |